ClinicalTrialsFinder

HER2-positive Recurrent or Metastatic Malignant Solid Tumor Clinical Trials in Zhengzhou

1 recruitingZhengzhou, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor

HER2-positive Recurrent or Metastatic Malignant Solid Tumor
Beijing Mabworks Biotech Co., Ltd.34 enrolled1 locationNCT03842085